Blackstone-managed private equity funds have agreed to acquire Japanese specialty pharmaceutical firm Ayumi Pharmaceutical from an independent private equity firm Unison Capital. Based in Tokyo, Ayumi is engaged in the manufacturing and marketing of various […]
A new device developed by researchers at the Massachusetts Institute of Technology (MIT) could transform the way drugs for tuberculosis (TB) are delivered into the body. As one of the world’s deadliest diseases, TB kills […]
Swiss pharma giant Roche has announced that the European Commission (EC) has approved its drug MabThera (rituximab) for rare autoimmune disease pemphigus vulgaris (PV). This makes MabThera the first biologic to be approved in the […]
A recently conducted study found that a commonly used drug for high blood pressure and angina (chest pain) is associated with increased risk of sudden cardiac arrest. The findings of the study, called European Sudden Cardiac […]
Merck KGaA, Darmstadt, Germany, is collaborating with Iktos, a French start-up company specialized in artificial intelligence (AI) for new drug design, to further accelerate its drug discovery capabilities. Under The collaboration agreement will enable Merck […]